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Cytochrome P450CYP2J2 epoxygenase is an extrahepatic, membrane bound cytochrome P450 (CYP) that is primarily found in the
heart andmediates endogenous fatty acidmetabolism. CYP2J2 interactswithmembranes through anN-terminal
anchor and various non-contiguous hydrophobic residues. The molecular details of the motifs that mediate
membrane interactions are complex and not fully understood. To gain better insights of these complex pro-
tein–lipid interactions, we employed molecular dynamics (MD) simulations using a highly mobile membrane
mimetic (HMMM) model that enabled multiple independent spontaneous membrane binding events to be
captured. Simulations revealed that CYP2J2 engages with the membrane at the F-G loop through hydrophobic
residues Trp-235, Ille-236, and Phe-239. To explore the role of these residues, three F-G loop mutants were
modeled from the truncated CYP2J2 construct (Δ34) which included Δ34-I236D, Δ34-F239H and Δ34-I236D/
F239H. Using the HMMM coordinates of CYP2J2, the simulations were extended to a full POPC membrane
which showed a signiﬁcant decrease in the depth of insertion for each of the F-G loop mutants. The CYP2J2 F-
G loop mutants were expressed in E. coli and were shown to be localized to the cytosolic fraction at a greater
percentage relative to construct Δ34. Notably, the functional data demonstrated that the double mutant, Δ34-
I236D/F239H,maintained native-like enzymatic activity. Themembrane insertion characteristicswere examined
by monitoring CYP2J2 Trp-quenching ﬂuorescence spectroscopy upon binding nanodiscs containing pyrene
phospholipids. Relative to the Δ34 construct, the F-G loop mutants exhibited lower Trp quenching and mem-
brane insertion. Taken together, the results suggest that the mutants exhibit a different membrane topology in
agreement with the MD simulations and provide important evidence towards the involvement of key residues
in the F-G loop of CYP2J2.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The cytochrome P450 (CYP) superfamily is a class of heme-
containing enzymes that are widespread throughout all kingdoms of
life [1]. In humans, CYPs mediate the biotransformation of both xenobi-
otics and endogenous substrates for homeostasis [2]. Eukaryotic CYPs
interact with membrane bilayers through an N-terminal anchor asc reticulum; ND, nanodisc; PYR,
ular dynamics; HMMM, highly
-sn-glycero-3-phosphocholine;
-3-phospho-L-serine; PYR-ND,
tive Biosciences, University of
ent of Biochemistry, Universitywell as various non-contiguous hydrophobic residues that constitute
the monofacial membrane-binding domain [3,4].
The CYP interaction with the membrane bilayer is a complex
phenomenon that is an active area of both experimental and computa-
tional research. While seminal studies correctly identiﬁed the general
nature of the protein-membrane binding and topology [5], more recent
examples have elucidated the interactions at themolecular and atomis-
tic levels [6–8]. Notably, P450 interactions with membranes have been
shown to regulate ligand binding mechanisms [9], membrane depth of
insertion [10], redox potentials [11], enzyme stability [12], structure
and orientation [6]. Additionally, advanced computational approaches
have revealed the dynamic nature of CYPs and how their hydrophobic
motifs interact with the membrane bilayer [6,8]. Both experimental
and computational approaches have revealed that CYPs are inserted
within the membrane, with a partially imbedded active site and deeply
immersed N-terminus and F-G loop [13,14].
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of both omega-3 and omega-6 polyunsaturated fatty acids into a num-
ber of biologically active metabolites [15]. Importantly, CYP2J2 is highly
expressed in themyocardium and surrounding aortic epitheliumwhere
it has been shown to be a key regulator of cardiovascular homeostasis
[16]. The metabolism of arachidonic acid, an omega-6 polyunsaturated
fatty acid, by CYP2J2 produces 8 unique regio- and stereoisomers
known as epoxyeicostrienoic acids (EETs) that are collectively charac-
terized as anti-inﬂammatory and vasodilatory lipid mediators [17].
CYP2J2 is anchored within the endoplasmic reticulum [2]. The
presence of the hydrophobic membrane binding domains of CYP2J2
complicates its use in many biochemical assays due to its inherent ten-
dency to aggregate outside of the membrane environment. The
disruption of the protein–membrane interactions affords solubility
and enables structural elucidation through methods such as nuclear
magnetic resonance (NMR) and high resolution x-ray crystallography.
Currently, there are no reports of the successful solubilization and
subsequent crystallization of anymember of the CYP2J subfamily. How-
ever, this was achieved for other CYP2 family members including
CYP2C5, CYP2A6, CYP2C8, CYP2C9 and CYP2D6 [4,18–21]. Speciﬁcally,
soluble isozymes were engineered through a combination of deletions
and hydrophilic substitutions of targeted membrane binding regions
that resulted in increased expression yields and protein homogeneity.
For example, the solubility of CYP2C5 was increased by substituting
the N-terminus (Δ21) with MAKTSK, adding a four-residue histidine
tag at the C-terminus and incorporating ﬁve substitutions at the mem-
brane binding interface with the mutations N202H, R206E, I207L,
S209G, and S210T [4]. Similarly, CYP2C9 N-terminal (Δ29) residues
were replaced by MAKKTSSKGR, a four-histidine carboxy-tag and the
seven amino acid mutations (K206E, I215V, C216Y, S220P, P221A,Fig. 1. Insertion of CYP2J2 intomembrane. (A) (Top)Membrane binding of CYP2J2 capturedwith
POPC membrane and simulated for another 100 ns. The stick backbone of the heme is colored
shown in stick representation. (Bottom) Residues Trp-48, Trp-235, Ile-236 and Phe-239, ide
(B) (Top) Time series of the center of mass (COM) z-coordinate of the side chains Trp-48, Trp-
to insert into the membrane when its COM z-position is below the reference plane deﬁned by
grown POPC membrane to relax. The positions of the phosphorous (PO4) and nitrogen (chol
of the heme tilt angle of CYP2J2 in the HMMM and POPC membranes. The red dashed line ind
z-coordinate of pyrene molecules attached to phospholipids and of the Trp-48 and Trp-235
distribution of the z-coordinate PO4 group of each leaﬂet. The location of pyrene and Trp side cI222L and I223L) in the F-G loop [18]. Soon after, CYP2D6 was success-
fully crystallized by truncating the N-terminus, adding a four-histidine
tag at the C-terminus and mutating the F-G loop Leu-230 and Lue-231
with a combination of hydrophilic residues (Asn, Lys, His, Gln, Arg,
and Ser) [21]. Importantly, these changes afforded some of the ﬁrst
structural insights of mammalian P450s through high resolution x-ray
crystallography. However, membrane dissociation while maintaining
the native functional characteristics is an essential, yet difﬁcult step, in
the ﬁeld of CYP protein engineering.
The truncation of the membrane-spanning CYP N-terminus is the
most widely used strategy to disrupt protein–membrane interactions
[19–23]. Indeed, we previously demonstrated that the complete
truncation of the CYP2J2 N-terminus results in a construct with
signiﬁcantly increased solubility. Importantly, this truncated construct
(Δ34-CYP2J2) exhibited similar substrate turnover rates as the full
length CYP2J2 construct in model membranes [24]. Notably, Δ34
maintained its membrane insertion despite the N-terminal truncation
[24]. Accumulating evidence suggests that the F-G loop of CYPs
(Figs. 1A and 3A) is an essential mediator of membrane binding [25].
Additionally, the F-G loop is positioned at the mouth of the substrate
access tunnels and is thought to control the rate of substrate access
to the buried active site [26]. Unlike the N-terminal motif, the non-
conservative mutations within the F-G loop region often results in
signiﬁcantly altered enzymatic activity [27]. Thus far, strategies have
typically included random mutagenesis and substitution of alternative
CYP chimeras which are typically an exercise of trial-and-error [28].
In this study, we used molecular dynamics (MD) simulations in
conjunction with experimental studies to evaluate the role of the F-G
loop of CYP2J2 in membrane binding and insertion. Previously, MD
simulations have been used to study protein–membrane interactionstheHMMMmembrane in 40 ns. Themembrane-boundmodel of CYP2J2was extended to a
red, the F- and G-helices are blue with the remaining P450 colored light blue. Lipids are
ntiﬁed to interact with the membrane upon binding, are shown in stick representation.
235, Ile-236 and Phe-239 for the HMMM and POPC membranes. A side chain is assumed
the COM z-position of the PO4. The black dashed lines indicate the time allowed for the
ine) atoms of the lipids are show in brown and gray, respectively. (Bottom) Time series
icates the average for the heme tilt angle in the POPC membrane. (C) Distribution of the
side chains, obtained from separate simulations. The dashed brown lines indicate the
hains in the simulation is also shown.
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highly mobile membrane-mimetic (HMMM) model [31] to capture
spontaneous binding of CYP2J2 to the membrane. The HMMM model
employs short-tailed lipidswhile an organic solvent replaces the hydro-
phobic core of the membrane, resulting in increased lipid mobility. Due
to the enhanced lipid mobility, the model accelerates the association of
proteins with the lipid bilayer, and has been successfully employed to
capture membrane binding of a variety of peripheral and membrane
proteins including the GLA domain [31], cytochrome P450 3A4 [6],
talin [32], α-synuclein [33], synaptotagmin [34], and synaptobrevin
[35]. This approach enabled us to capture atomic level interactions
between CYP2J2 and the membrane. Importantly, these interactions
were preserved when the short-tailed lipids were extended to a full
POPC membrane. Secondly, after a membrane-bound model of CYP2J2
was obtained, we studied the effect of F-G loop mutations on
membrane-binding and insertion depth, by taking advantage of the
enhanced lipid dynamics of the HMMMmodel.
To experimentally support the MD ﬁndings, hydrophilic residues
were engineered in the CYP2J2 F-G loop. Subsequent studies revealed
the effects of the mutations on enzyme functionality, subcellular distri-
bution andmembrane binding characteristics. The details of the relative
depth of insertion were explored by measuring the mutants' intrinsic
tryptophan ﬂuorescence and energy transfer to pyrene phospholipids
incorporated in lipid bilayers.
Determining the degree of the Trp-pyrene ﬂuorescence resonance
energy transfer (FRET) is a widely usedmethod to probe the interaction
of both peripheral and membrane proteins with membrane bilayers.
Previously, liposomal systems were used to measure the Trp insertion
of membrane proteins such as CYP3A4 [10] and CYP1A2 [36] as well
as peripherally binding proteins such as cytochrome C [37] and 14-3-
3γ [38]. The use of nanodiscs in this application offers several advan-
tages over traditional liposomal systems. Speciﬁcally, nanodiscs are
nanoscale discoidal lipid bilayers that exhibit signiﬁcantly enhanced
stability and homogeneity relative to liposomal systems. Additionally,
nanodiscs are more easily concentrated without aggregation and lack
the typical scattering effects observed with liposomal systems [14,24,
39].
Overall this work provides novel insights on the role of key residues
in the CYP2J2 F-G loop and their effects on membrane binding and
functional metabolism. The use of MD simulations provides high
resolution interactions between the membrane and CYP2J2 F-G
loop. Experimentally, the introduction of hydrophilic residues in the F-
G loop provides essential functional data as well as an assay for
membrane depth of insertion. Understanding the nuances of these
interactions will enable new applications with CYP2J2 and other mem-
brane bound CYPs.
2. Methods
2.1. Molecular dynamical simulations: preparation of HMMMmembrane
The HMMM membrane was constructed starting from a solvated
POPC membrane by shortening the lipid tails to only 5 carbons [31],
while the remaining carbon atoms were converted to 1,1-dichloroeth-
ane (DCLE). This resulted in an HMMM membrane patch with two
leaﬂets of short-tailed PC lipids at the interface of water and DCLE, as
described in detail elsewhere [31]. The solvated HMMM membrane
contained 137 short-tailed PC lipids in each leaﬂet and 1268 DCLE
molecules, yielding a system with ~41,000 atoms. The solvated
membrane mimetic system was energy minimized for 2000 steps and
simulated for 1 ns using an NPnAT ensemble with constant area, and
with a target normal pressure and temperature of 1.0 atm and 310 K,
respectively. A constant area of 10, 281 Å2 (101.4 × 101.4 Å2) was
employed, yielding an area of 75 Å2 per lipid (AL), about 8% higher
than the experimental AL for POPC membranes [40]. Based on our
experience with other peripheral proteins, a mild increase in AL (5–8%) can signiﬁcantly accelerate membrane binding [31,33]. The
resulting membrane was employed in all subsequent binding simula-
tions ofwild-typeCYP2J2 and itsmutants. Tomimic the atomic distribu-
tions of a full lipid bilayer in the HMMM simulations more closely, a
harmonic constraint along the z-axis (membrane normal) with a force
constant k=0.05 kcal·mol−1 · Å−2 was applied to the carbonyl carbon
atoms of the short-tailed PC lipids.
2.2. CYP2J2 model and initial conﬁgurations
A homology model of the catalytic domain of CYP2J2, generously
provided by Dr. D. Mansuy (Université René Descartes, Paris France),
was employed as the starting structure of CYP2J2 for this study. The
homology model was derived using the available crystal structures of
CYP2A6 (PDB: 1Z11), CYP2B4 (PDB: 2BDM), CYP2C5 (PDB: 1NR6),
CYP2C8 (PDB: 1PQ2), and CYP2D6 (PDB: 2F9Q) as templates, as
previously described [41]. The sequence identity of the template
structures with CYP2J2 ranged from 41% to 45%. The individual
sequence identity of each template with CYP2J2 is as follows: CYP2A6:
42%; CYP2B4: 45%; CYP2C5: 41%; CYP2C8: 42%; CYP2D6: 42%. Initially,
the CYP2J2 structure was relaxed by placing the enzyme in a water
box with dimensions of 90 × 90 × 90 Å3, containing ~20,000 water
molecules, generated with the SOLVATE plugin of VMD [42], and
neutralized with 100 mM NaCl ions using the AUTOIONIZE plugin. The
system was then energy minimized for 2000 steps and simulated for
100 ps with the Cα atoms of the protein harmonically restrained
(k = 1 kcal·mol−1·Å−2), and followed by 100 ns run with no
constraints. The resulting structure of CYP2J2 was used as the initial
structure for simulations.
For the membrane-binding simulations, wild-type CYP2J2 was
placed ~10 Å above the surface of the HMMMmembranewith different
initial orientations (50° and 80° with respect to the z-axis). Three initial
systems were prepared for simulation, two of which started from the
same initial orientation (80°). The resulting structure was further
solvated using the SOLVATE plugin, and neutralized with 100 mM
NaCl using the AUTOIONIZE plugin of VMD [42]. Each of the three
resulting initial systems consisted of a box with dimensions of
101.4 × 101.4 × 122.0 Å3 and containing ~120,000 atoms. The systems
were energy minimized for 2000 steps and relaxed further for 100 ps
with the Cα atoms of the protein harmonically restrained (k = 1
kcal·mol−1·Å−2), followed by 40 to 60 ns of production simulation.
To study the effect of F-G loop mutations on membrane binding of
CYP2J2, themutations I236D, F239H, and I236D/F239Hwere introduced
in the last frame of eachmembrane-binding simulation of thewild-type
CYP2J2. This approach allowed us to take advantage of the accelerated
lipid dynamics to monitor changes in the membrane insertion of
CYP2J2 induced by the mutations. The Asp residue in the mutants was
modeled in its deprotonated (charged) form, while the His residue
was modeled in its neutral form, to match the expected charge of
these side chains at pH 7.4. The resulting systems were energy
minimized for 1000 steps and relaxed further for 100 ps with the Cα
atoms of the protein, except for the mutated residues, harmonically
restrained (k=1 kcal·mol−1·Å−2), followed by 40 to 50 ns of produc-
tion simulation.
The resultingmodels ofmembrane-boundCYP2J2 and itsmutants in
the HMMM membrane were extended to a full POPC membrane, to
perform additional simulations. A membrane-bound model of the
CYP2J2 for each case (wild-type and mutants) was adopted from the
last frames of one of the HMMM membrane-binding simulations
described above. The short-tailed lipid bilayer was transformed into
a POPC bilayer by removing the DCLEmolecules and adding themissing
carbons of the lipid tails. The positions of the added lipid tail atomswere
reﬁned based on the coordinates of randomly selected lipid molecules
obtained from a POPC bilayer equilibrated separately. During these
steps, the positions of the lipid atoms already present in the HMMM
membrane (headgroups and the initial ﬁve carbons of the lipid tails)
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the lipids and CYP2J2 during the HMMM simulations. The resulting
POPC-bound CYP2J2 systems were then minimized for 2000 steps and
equilibrated for 100 ps while restraining all the protein and short-
tailed lipids atoms with a force constant k = 1 kcal·mol−1·Å−2 to
allow relaxation of the newly added lipid tail atoms. Following this
step, the resulting wild-type and mutants systems were simulated
without restraints for 70 to 100 ns.
2.3. Pyrene phospholipid partitioning in the membrane
In order to gain a more detailed description of the partitioning and
orientation of pyrenemolecules in a lipid bilayer, we performed another
set of MD simulations. A solvated POPC membrane containing one
pyrene phospholipid in each leaﬂet was constructed to study the
dynamics of pyrene in the membrane. A POPC molecule was employed
as a template to generate the pyrene-attached phospholipid, by remov-
ing carbons from the acyl tail and replacing them by a pyrene moiety.
The resulting system was then minimized for 1000 step and simulated
for 1 ns with the heavy atoms of the lipid head groups harmonically
restrained (k = 1 kcal·mol−1·Å−2), except for the pyrene phospho-
lipids. The step was then followed by a 50 ns production simulation.
2.4. Simulation conditions and protocols
All simulations were performed with NAMD2 [43] using the
CHARMM27 [44] force ﬁeld with cMAP corrections for the protein and
CHARMM36 [45] for lipids. Parameters of the pyrene-attached
phospholipid were derived by analogy from the CHARMM General
Force Field [46,47]. The TIP3P model was used for water [48]. The
NPnAT ensemble at 1.0 atm and 310 K, with a constant area of
10,281 Å2 (101.4 × 101.4 Å2), was employed for all HMMMsimulations.
The POPC systems were simulated as an NPT ensemble at the same
pressure and temperature. All simulations were performed with a
time step of 2 fs. Constant pressurewasmaintained by theNosé–Hoover
Langevin piston method [49,50] and constant temperature was main-
tained by Langevin dynamics with a damping coefﬁcient γ of 0.5 ps−1
applied to all atoms. A cutoff of 12 Å was used for nonbonded interac-
tions, with a smoothing function applied after 10 Å. The particle mesh
Ewald (PME) method [51] was used for long-range electrostatic
calculations with a grid density greater than 1 Å−3.
2.5. Materials
Ampicillin, arabinose, chloroamphenicol and IPTG were procured
from Gold Biotechnology. NADPH and NADP were obtained from
P212121.com. Protein standards—thyroglobulin, ferritin, bovine serum
albumin, and cytochrome c, were purchased from Sigma. Phospholipids
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-
hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-L serine
(POPS) were purchased from Avanti Polar Lipids. The phospholipid 1-
hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphocholine
(PYR-PC) was obtained from Life Technologies. Amberlite XAD 2 was
procured from Supelco. Nanosep MF (0.2 μM) and Amicon Ultra
(10,000 MWCO) centrifugal ﬁlters were bought from Millipore. AA
and ebastine were purchased from Cayman Chemical. All other mate-
rials and reagents used were purchased from Sigma-Aldrich and Fisher
Scientiﬁc.
2.6. Heterologous expression and puriﬁcation of the CYP2J2 F-G loop
constructs
The N-terminally truncated CYP2J2 construct (Δ34) was heterolo-
gously expressed and puriﬁed as described previously [24,52]. The
mutations for the F-G loop plasmids were prepared using the reverse
primers listed in Fig. S3 and ampliﬁed by polymerase chain reaction(PCR) on the pCWori Δ34 plasmid in conjunctionwith theΔ34 forward
primers. Each F-G loop mutant plasmid was co-transformed with
the GroEL plasmid and grown in an overnight culture and used for
inoculation of 1 L of terriﬁc broth (TB) media supplemented with
ampicillin (100 μg/mL) and chloramphenicol (20 μg/mL). The culture
was grown at 37 °C and 220 rpm for 2.5 h and then supplemented
with δ-aminolevulinic acid (0.5 mM) and maintained at 26 °C and
160 rpm for 2 h. Next the culture was induced with 1 mM of Isopropyl
β-D-1-thiogalactopyranoside (IPTG) and 2 g of arabinose and grown
for an additional 44 h. The cells were isolated via centrifugation for
10 min (2800 g) using a JA-10 rotor (Beckman Coulter, Brea CA) and
sonicated in lysis buffer containing dithiothreitol (DTT), 0.2 mM
phenylmethanesulfonylﬂuoride (PMSF), 5 mg DNase, and RNase. The
membrane fraction was isolated via ultracentrifugation at 35,000 rpm
from30min Ti-45 rotor (Beckman) and the soluble fractionwas collect-
ed for analysis of the CYP content. Protein was extracted using 1%
cholate (w/v) and the supernatant layer containing CYP2J2 was
obtained by ultracentrifugation 35,000 rpm from 30 min Ti-45 rotor
(Beckman). The histidine tagged protein was further puriﬁed by
running the supernatant through a Ni-NTA column and eluted with
0.1 mM DTT, 0.1% (w/v) cholate, 100 mM KPi, 200 mM imidazole and
20% glycerol. CYP2J2 concentration was measured by carbon monoxide
difference spectra as described below.
2.7. Puriﬁcation of oligomeric CYP2J2 by size-exclusion chromatography
For the membrane binding studies, the resulting Ni-NTA eluent was
further puriﬁed using size exclusion high performance liquid chroma-
tography (SEC-HPLC) on a semi-preparative Superdex 200 10/300
column (GE Life Sciences, Piscataway, NJ) with a mobile phase
consisting of 100 mM phosphate buffer (pH 7.4), 1 mM EDTA, 0.5 M
NaCl, 2% glycerol and 0.1% cholate at a 0.5 ml/min ﬂow rate. The
predominant peak of each construct was collected and adjusted to
contain 20% glycerol and concentrated using Amicon Ultra (10,000
MWCO) centrifugal ﬁlters (Millipore). The resulting protein concentra-
tion was quantiﬁed using a Micro BCA protein assay kit (Thermo Sci
#23235). Next, the concentrated protein was examined for homogene-
ity (Fig. 3C) by injecting 20 μL on a high resolution Superdex 75 10/30
SEC column (GE Life Sciences, Piscataway, NJ) with a mobile phase
consisting of 100 mM phosphate buffer (pH 7.4), 1 mM EDTA, 0.5 M
NaCl, 2% glycerol and 0.1% cholate at a 0.5 mL/min ﬂow rate. The
oligomeric state of the CYP2J2 constructs was estimated using the
same mobile phase and Superdex 75 10/30 column for the generation
of a standard curve plotted using thyroglobulin (669 kDa), ferritin
(440 kDa), BSA (67 kDa), and cytochrome c (14 kDa) as protein stan-
dards (Fig. S5).
2.8. Expression and puriﬁcation of cytochrome P450 reductase
Cytochrome P450 reductase (CPR) from Ratticus norvegicus was
expressed and puriﬁed as previously described [24].
2.9. Construction of ΔTrp-MSP1D1
In order to obtain ΔTrp-MSP1D1, the EcoR1-Sac1 gene fragment of
MSP1D1 was replaced by the synthetic gene fragment in which two
tryptophan codons (TGG) were substituted by phenylalanine codons
(TTC). An additional silentmutationwas added to create new restriction
site (Xba1) in order to facilitate the screening. Brieﬂy, the 300 bp G-
block fragment (synthesized by IDT DNA, Inc.) and MSP1D1 plasmid
were digested with Eco R1 and Sac1 restriction endonucleases. After
separation on agarose gel, the 5.7 kBp fragment of MSP1D1 plasmid
was ligated using T4 ligase. After initial identiﬁcation of the mutant
clones by digestion mapping, the presence of the desired mutations
were conﬁrmed by DNA sequencing. MSP expression and puriﬁcation
was performed as described earlier [53].
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The carbonmonoxide binding characteristics of the constructs were
measured after Ni-NTA puriﬁcation using a modiﬁed version of Omura
and Sato's method [54] as described previously [24,39,55].
2.11. Guanidine hydrochloride induced denaturation of CYP2J2
The denaturation of CYP2J2 protein was studied by measuring the
change in Soret at 417 nm as a function of increasing concentration of
Gd-HCl (0 to 6 M) as previously described [56]. Solutions containing
varying concentrations of guanidinium hydrochloride were incubated
with ~2 μM of CYP2J2 for 5 min before measuring their UV–Vis spectra
(800–300 nm). The resulting spectra were then processed using a
MATLAB subroutine for determination of Soret absorbance changes.
2.12. Arachidonic acid metabolism assay for measurement of EETs
Incubations contained empty POPC-nanodiscs (10 μM), CYP2J2
(0.2 μM), CPR (0.6 μM) and 100 mM phosphate buffer (pH 7.4) and ar-
achidonic acid (40 μM) near the critical micelle concentration. Themix-
ture was equilibrated at 37 °C for 10 min before reaction initiation with
200 μM NADPH (total volume 500 μL) and was allowed to react for
30 min. CYP2J2-Δ34 AA metabolism linearity over a one hour time
course was previously conﬁrmed [39]. Samples were quenched upon
extraction with an equal volume of ethyl acetate (3 times), dried
under a steady streamof nitrogen and reconstituted in ethanol. Samples
were analyzed using a 1200 series HPLC (Agilent Technologies, Santa
Clara, CA) coupled to a 5500 QTRAP LC-MS/MS system (AB Sciex, Foster
City, CA) for EET quantiﬁcation using LC–MS/MS as previously described
[39].
2.13. Assembly of POPC nanodiscs
POPC was solubilized with cholate (50 mM) and mixed with the
membrane scaffold protein ΔTrp-MSP1D1 (devoid of Trp ε280 =
10,040 mM−1 cm−1) in a 65:1 ratio before rocking the mixture at 4 °C
for one hour. Nanodisc assembly was initiated upon removal of deter-
gents using of Amberlite Biobeads (Supelco). The homogenous nanodisc
assembly was isolated using SEC-HPLC with a Superdex 200 10/300
column (GE Life Sciences, Piscataway, NJ) and amobile phase consisting
of 100 mM phosphate buffer (pH 7.4) and a 0.5 mL/min ﬂow rate. The
isolated nanodiscs were then concentrated with Amicon Ultra (10,000
MWCO) centrifugal ﬁlters (Millipore) to a ﬁnal concentration of 500 μM.
2.14. Assembly of POPC-PYR nanodiscs
Nanodiscs containing PYR-PCwere preparedwith the samemethod-
ology as the POPC nanodiscs with a minor adaptation. Speciﬁcally,
the PYR-PC was added to the POPC mixture in a 1.5:98.5 molar
ratio. The phospholipids were then mixed with MSP1D1 in a 65:1
ratio and allowed to equilibrate for 1 h at 4 °C before detergent
removal with Amberlite Biobeads. The assembled nanodiscs were
isolated using SEC-HPLC on a Superdex 200 10/300 column (GE Life
Sciences, Piscataway, NJ) with a mobile phase consisting of 100 mM
phosphate buffer (pH 7.4) and a 0.5 mL/min ﬂow rate (Fig. 4B). Desired
concentration of the incorporated PYR-PC was conﬁrmed in solution
spectrophotometrically at 342 nmusing themolar extinction coefﬁcient
42 mM−1 cm−1 (Fig. 4B inset).
2.15. Assembly of POPC–PYR–POPS nanodiscs
Nanodiscs containing PYR-PC were prepared as described for the
POPC–PYR nanodiscs, albeit with the addition of differing ratios of
anionic phospholipids (POPS). Nanodiscs containing 30% and 60%
POPS were prepared by mixing POPC/PYR/POPS in a molar ratio of68.5:1.5:30 and 38.5:1.5:60, respectively. Each POPC/PYR/POPSmixture
was added to MSP1D1 in a 65:1 ratio and allowed to equilibrate for 1 h
at 4 °C before detergent removal with Amberlite Biobeads. The
assembled nanodiscs were isolated using SEC-HPLC on a Superdex 200
10/300 column (GE Life Sciences, Piscataway, NJ) with a mobile phase
consisting of 100 mM phosphate buffer (pH 7.4) and a 0.5 mL/min
ﬂow rate.
2.16. Steady state ﬂuorescence titration experiments
Steady state ﬂuorescencemeasurementswere performed using a K2
multi-frequency phase and modulation ﬂuorometer (ISS, Urbana, IL,
USA). Fluorescence experiments utilized puriﬁed monomeric CYP
(1 μM), nanodiscs (50 μM), 100 mM phosphate buffer (pH 7.4) and
1 mM Na-EDTA maintained at 25 °C with a circulating water bath.
Emission spectra of the intrinsic ﬂuorescence of the CYP interacting
with nanodiscs were recorded from 300 to 400 nm with an excitation
of 295 nm and bandwidths of 8 nm for both excitation and emission
measurements. The maximal initial ﬂuorescence (Fo) was measured
by preparing samples containing CYP and ΔTrp-MSP1D1 POPC
nanodiscs (50 μM), incubating for 10 min and recording the emission
spectra. The quenched ﬂuorescence measurement (F) was recorded
after an incubation (10 min) of individually preparing samples contain-
ing CYP with pyrene nanodiscs (50 μM) comprised of ΔTrp-MSP1D1
POPC, ΔTrp-MSP1D1 POPC/POPS (70:30), or ΔTrp-MSP1D1 POPC/
POPS (40:60). A parallel sample devoid of CYP was recorded after each
measurement and subsequently subtracted from the main spectra
using Vinci 2 software (Urbana, IL, USA). Samples were analyzed for
changes in the Trp ﬂuorescent maxima (λmax) as well as for the ratio
of changes in the initial ﬂuorescent intensity (Fo) and ﬁnal ﬂuorescence
(F).
2.17. Data analysis
Data were analyzed and presented as means ± standard error. Data
were collected multiple times and were analyzed for statistical
signiﬁcance using a Student's paired t test where *p b 0.05, **p b 0.01,
and ***p b 0.001.
3. Results and discussion
3.1. Molecular dynamics simulations —membrane-bound form of CYP2J2
In order to generate a membrane-bound model of CYP2J2 which
would allow us to better understand the key lipid–protein interactions
involved in membrane binding of the protein, we performed three
independent MD simulations between 40 and 60 ns, starting with the
Δ34-CYP2J2 placed above a phosphatidyl choline (PC) HMMM lipid bi-
layer. The aim was to capture the spontaneous membrane binding and
insertion of the protein into lipid bilayer in unbiased simulations.
Owing to the enhanced lipid dynamics of themembranemodel, sponta-
neous membrane binding of the catalytic domain of CYP2J2 was
consistently observed during these simulations (Fig. 1A). The analysis
of the three resulting simulations reveals a similar behavior in terms
of depth of insertion and orientation in the membrane of CYP2J2
(Figs. 1B and S1). The resulting binding pose of CYP2J2 suggests that
the enzyme can interact with the membrane through hydrophobic
residues located in the F-G loop region, in particular residues Trp-235,
Ille-236 and Phe-239. During the simulations, these side chains were
observed to insert in the membrane (i.e., positioning below the refer-
ence plane deﬁned by the PO4 level) (Fig. 1B). The N-terminal loop
formed containing residue Trp-48 is also observed to insert into the
membrane after binding (Fig. 1B).
Starting from the HMMMmembrane-bound models of CYP2J2, the
short-tailed lipids (with ﬁve carbons in each tail) were extended to
full POPC lipids (see Section 2), resulting in a model of CYP2J2 bound
Fig. 2. Effect of F-G loopmutations inmembrane-binding of CYP2J2. Time series of the COMz-
position of side chains Trp-48, Trp-235, Ile-236 and Phe-239 for the HMMM and POPC
membranes shown for (A) I236D/F239H mutant, (B) I236D mutant and (C) F239H
mutant. For each case, the HMMM simulations were extended to a POPC membrane and
simulated 80 ns. The black dashed lines indicate the time allowed for the extended
POPCmembrane to relax after conversion fromHMMM. The positions of the phosphorous
(PO4) and nitrogen (choline) atoms of the lipids are show in brown and gray, respectively.
(D) Average relative position of the COM z-coordinate of the side chains forming the
F-G loop (residues 225 to 240) with respect to the reference plane deﬁned by the
COM z-position of the PO4. The average was taken from the last 20 ns of simulations
for each case. The error bars represent one standard deviation.
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tion shows that themain interactions observed in theHMMMmodel are
preserved, and Trp-48, aswell as residues Trp-235, Ile-236 and Phe-239
located in the F-G loop remain inserted in the membrane (inserted
below the PO4 level) (Figs. 1B and S1). In order to test the convergence
of the membrane-bound models of CYP2J2, we characterized the
orientation that the enzymewith respect to the lipid bilayer by calculat-
ing the heme tilt angle, deﬁned as the angle between the heme plane
(deﬁned as the plane containing the four porphyrin nitrogen atoms)
and membrane normal (z-axis). In the three extended POPC simula-
tions, the heme tilt angle converges to values ~50°, suggesting a conver-
gent membrane-bound pose for CYP2J2. The orientation that CYP2J2
adopts in the membrane is similar to that reported for other
membrane-bound CYPs, measured both from experiments and from
simulations, which are reported to be around 60 to 70° [6,57].
3.2. Simulation of pyrene partitioning in the membrane
Weperformed experiments to evaluate the interaction of themutat-
ed CYP2J2 proteins with membranes by measuring the Trp quenching
by pyrene phospholipids inserted into the homogeneous lipid bilayer.
Therefore, in order to identify potential interactions between a pyrene
molecule attached to a phospholipid and the membrane-bound
CYP2J2, we performed a separate simulation of a POPC membrane
containing a single pyrene phospholipid in each leaﬂet for 50 ns in the
absence of CYP2J2. The goal was to characterize the distribution of the
pyrenemolecules within the lipid bilayer and use it to infer information
on the potential interaction of the side chains of CYP2J2 with pyrene
upon membrane binding based on the location of this moiety in the
membrane. The distribution of the z-position for each molecule
revealed that the pyrene moiety is located mainly in the hydrophobic
core of the membrane, below the phosphate groups (Fig. 1C). Despite
being attached to their respective phospholipid tail, pyrene molecules
are able to sample awide range of insertion depthwithin the hydropho-
bic core of themembrane, as indicated by theirwide z-position distribu-
tions. Interestingly, the insertion depth of CYP2J2 in the POPC
membrane would allow for the side chains of Trp-48 and Trp-235 to
interact with the pyrene moiety located in the PYR-ND, as indicated
by their z-position distributions (Fig. 1C). The distribution of the z-
position of each side chain shows that they both insert to a similar
level around the PO4 level, with Trp-235 slightly more inserted than
Trp-48. Therefore using PYR-ND one can delineate the membrane
interactions of the CYP2J2 mutants with the lipid bilayer using experi-
mental approaches as described later.
3.3. CYP2J2 construct design
The initial structural analysis and MD simulations suggested two
hydrophobic residues in the F-G loop, Ile-236 and Phe-239, as putative
membrane anchors (Figs. 1A and 3A). These sites were mutated to
hydrophilic residues with the aim of altering membrane-binding
characteristics by decreasing the overall hydrophobicity of this region.
To this end, two single mutations, I236D (Δ34-I236D) and F239H
(Δ34-F239H), as well as a construct containing both I236D and F239H
(Δ34-double) were designed. Apart from the N-terminal anchor, the
CYP F-G loop has been hypothesized to be the primary membrane-
binding motif. This assumption is further supported by the observation
that the greatest structural differences between the soluble prokaryotic
CYPs and themembrane boundmammalian CYPs are found in the F and
G helices and the F-G loop [58]. Notably, CYP2D6 was successfully
solubilized and crystallized by truncating the N-terminus andmutating
the F-G loop Leu-230 and Leu-231 with a combination of hydrophilic
residues that included I230D and I231R [21]. Following a similar design
strategy we mutated Ile-236 and Phe-239 to hydrophilic residues
to examine the effects on solubility and functionality. Additionally,
the close proximity of the naturally occurring Trp-235 to themutated sites enabled membrane-binding studies using ﬂuorescence
spectroscopy.
3.4. Molecular dynamics simulations of membrane binding modes of the
F-G loop mutants
We studied the effect of these speciﬁc F-G loop mutations
on membrane binding of CYP2J2 by introducing the mutations in
the membrane-bound models obtained from MD simulations. To
achieve this, we used the ﬁnal snapshot of each of the three
HMMM membrane-binding simulations, introduced the mutations
and performed production simulations on the system. This approach
allowed us to monitor changes in the membrane insertion depth of
the protein due to mutations in the F-G loop. Single mutations Δ34-
I236D and Δ34-F239H, as well as double mutation Δ34-double were
introduced in the membrane-bound CYP2J2, resulting in 3 models for
each mutant, which were simulated individually between 40 and 50 ns.
The results of these simulations show that the mutations affect the
insertion of the F-G loop to various degrees (Fig. 2). The I236Dmutation
promotes the detachment of Trp-235 from the membrane. In the cases
were this mutation is introduced (I236D and 1236D/F239H), Trp-235
moves from a fully inserted position to an average position that is
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residue from the membrane (Fig. 2A and B). In both cases, the position
of Trp-235 side chain (above the phosphate level) is maintained upon
the conversion of the HMMMmembrane with short-tail lipids to a full
POPC membrane (Fig. 2A and B). In the POPC membrane, the average
position of Trp-235 resulting from the I236D mutation is between 5
and 10 Å above the reference PO4 plane, as shown in Fig. 2D. The
F239H mutation, on the other hand, seems to have a smaller effect on
Trp-235 insertion, causing only transient detachment of Trp-235 bothFig. 3. Biochemical characterization of the CYP2J2 F-G loop mutants. (A) Representation of the CY
helices are dark blue with the remaining P450 protein fold and helices colored light blue. T
represented by cyan. (B) The three CYP2J2 mutants Δ34-I236D, Δ34-F239H and Δ34-double w
from the membrane fraction whereas the line plot signiﬁes percentage of CYP found in the so
protein was examined for homogeneity and elution volume with a high resolution Superdex
monitoring the loss of the prosthetic hememonitored at 417 nmusing UV–Vis spectroscopy in
functionality was gauged bymonitoring themetabolism of arachidonic acid (40 μM) using LC/M
total EET consisting of 14,15-, 11,12-, 8,9- and 5,6-EETwere determined for thewild-type constr
statistical signiﬁcance belowp b 0.05when using a paired, two-tailed student's t-test but did see
respectively.in the short-tail lipid membrane and in the POPC membrane (Fig. 2C),
resulting on an average relative position that is close to the Trp-235
insertion in thewild type case (Fig. 2D). Taken together, the simulations
indicate that introducing mutations in the F-G loop results in a
shallower membrane insertion of Trp-235 in the F-G loop when
compared to the wild-type simulations. As discussed later, this was
corroborated by an increased percentage of themutants in the cytosolic
fraction and ﬂuorescence experiments where we measured CYP2J2 Trp
quenching by membranes containing pyrene lipids.P2J2 Δ34 homology model. The stick backbone of the heme is colored red, the F- and G-
he two residues selected for mutation (I236 and F239) are colored red on the F-G loop
ere recombinantly expressed in E. coli. The bar graph denotes expression yields puriﬁed
luble fraction during puriﬁcation. (C) The size exclusion chromatography puriﬁed CYP2J2
75 10/30 column. (D) Changes to the stability of each CYP2J2 construct was assessed by
the presence of increasing concentrations of guanidine hydrochloride. (E) F-G loopmutant
S/MS in a nanodisc reconstituted system. The rate of the conversion of arachidonic acid to
uct and eachof the three F-G loopmutants. In the arachidonic acid assaywedid not observe
a trend towards signiﬁcance forΔ34-I236D andΔ34-F239Hwith p-values of 0.1 and 0.18,
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The growths of all constructs were performed in DH5alpha cells due
their relatively slow growth and expression characteristics that improve
the overall yields of functional P450 [52]. We previously demonstrated
that the N-terminus truncated CYP2J2 construct (Δ34) exhibited
greater solubility, yet still maintained its ability to insert in the mem-
brane bilayers of nanodiscs [24]. Interestingly, the percentage of protein
found in the soluble fraction during puriﬁcation corresponded to the
number of F-G loop mutations. Speciﬁcally, the percentages of protein
in the soluble fraction of Δ34-double, Δ34-I236D, Δ34-F239H and Δ34
were 56.7%, 46.3%, 43.8% and 37.5%, respectively (Fig. 3B). These results
provide the expression and membrane binding characteristics of the
CYP constructs in the E. coli membrane. The ratio of the membrane to
soluble fraction of the protein only provides an indication of enzyme
solubility and is not directly applicable to other systems such as model
membranes and mammalian cells. Therefore we further explored the
membrane insertion of these constructs using a Trp quenching assay
in Nanodiscs as described later.
3.6. Spectral characterization, denaturation studies, and size-exclusion
chromatography of the F-G loop mutants
The F-G loopmutants exhibited typical Soret and Q-bands similar to
wild type CYP2J2 (data not shown). To investigate the potential heme-
thiolate perturbations the mutants were reduced (FeII) and bound with
carbon monoxide. All constructs exhibited a prominent 451 nm peak,
albeit with some 420 nm peak, indicating that the charged mutations
in the F-G loop did not largely perturb the heme-thiolate motif interac-
tions and the common P450-fold (Fig. S4). Furthermore, the stability of
the mutants was assessed by performing guanidine hydrochloride
denaturation studies using UV–Vis spectroscopy. The 417 nm Soret
absorbance is attributed to the uniquely coordinated ferric (FeIII)
heme. In the presence of increasing concentration of guanidine hydro-
chloride (Gd-HCl), the absorbance of the CYP at 417 nm decreased,
indicating heme loss due to protein unfolding [56]. The three constructs
demonstrated comparable stability in Gd-HCl with a decrease in peak
intensity of ~45%. The Δ34 construct exhibited less denaturation with
an overall 30% decrease in the Soret peak intensity in the presence of
6 M Gd-HCl (Fig. 3D).
The range of oligomers formed from each mutant after Ni-NTA
puriﬁcation was examined using semi-preparative size exclusion
chromatography All the constructs produced a predominant peak that
eluted at a volume of ~15.5 ml on the Superdex 200 10/300 column
(data not shown) using the conditions listed in the materials and
methods. The primary oligomer was collected, concentrated and its
homogeneity and molecular weight was assessed using a high resolu-
tion Superdex 75 10/30 column. As seen in Fig. 3C, all the constructs
show a single oligomer that corresponded to the monomeric form
of the protein as measured using protein standards (Fig. S5). Taken
together, the results suggest that the non-conservative mutations did
not change the protein in regards to P450 fold, oligomeric state and
stability.
3.7. Arachidonic acid metabolism
Typically, random introduction of mutations in the F-G loop of CYPs
alters their function as compared to thewild type construct [27]. There-
fore we examined the effect of the F-G loop mutation on the CYP2J2
mediated metabolism of arachidonic acid (AA) in the presence of a
50 μM concentration of empty POPC nanodiscs. As discussed in the
steady state ﬂuorescence section, a CYP to nanodisc stoichiometric
ratio of 1:50was chosen to ensure that the CYP constructwas complete-
ly bound to nanodiscs. Under these conditions, the functional
differences between CYP2J2 are results of differences in their ability to
metabolize AA and not due to discrepancies between the membrane-bound and unbound states. AA is a slowly metabolized endogenous
substrate that forms EET metabolites that are potent vasodilators and
anti-inﬂammatory lipids [17,59]. The metabolism of AA is complex, as
it produces four unique epoxide regio-isomers. Interestingly, the Δ34-
I236D metabolism of AA was increased with a ~1.6 greater catalytic
efﬁciency of all regio-isomers when compared to Δ34 (Fig. 3E).
Conversely, the function of Δ34-F239H was dramatically decreased
relative to Δ34, indicating that the mutant's native function has been
altered. Notably, the Δ34-double construct produced the EET metabo-
liteswith similar catalytic efﬁciency toΔ34 as shown in Fig. 3E. Interest-
ingly, none of the mutations altered the ratio of the EET products
produced by CYP2J2 (data not shown), which suggests that the active
site was not drastically altered.
In bothmammalian and bacterial systems, the F-G loop is an impor-
tant regulator of substrate access channels [60]. Moreover, this region
has been shown to be ﬂexible with open/closed conformations and
provides the roof of the internal substrate-binding pocket which
mediates substrate recognition [61]. Recent evidence suggests that the
conformation of the F-G loop and ligand type may alter ligand egress
routes. Speciﬁcally, MD simulations predicted that the non-helical
CYP2C9 F-G loop would favor egress pathways through the membrane
bilayer [62]. In this work we demonstrate that single mutations in this
region can alter the catalytic turnover characteristics of the epoxidation
of arachidonic acid (Fig. 3E). Interestingly, the enhanced catalytic func-
tionality of Δ34-I236D or decreased activity of Δ34-F239H did not alter
the enzyme regioselectivity and therefore cannot simply be rationalized
based on their enhanced solubility or active site alteration. Rather these
changes suggest that the introduction of the acidic residue either alters
the loop conformation dependent egress pathways and/or substrate
recognition sites. Notably, these effects are abolished in the Δ34-
double construct, which restores wild-type activity.
While only a fraction of histidine is charged at physiological pH, this
may be an important stabilizing residue. The combination of an anionic
and cationic residue introduction was selected for the crystallization of
CYP2D6 due to its restoration of wild-type like activity [21]. Important-
ly, these mutations were chosen as a practice of trial-and-error. The ra-
tional introduction of the double mutation in CYP2J2 F-G loop
corroborates this strategy. However, MD simulations demonstrated
that although there is a close interaction of the side-chains there was
no apparent salt-bridge formation (data not shown).
3.8. CYP2J2 construct membrane insertion into pyrene nanodiscs
To investigate the CYP2J2 constructs' insertion in the membrane
bilayer, we measured the relative Trp quenching energy transfer
between the proteinmonofacial Trp residues and pyrene phospholipids.
To this end, we prepared nanodiscs with pyrene phospholipids (PYR-
ND) using the ΔTrp-MSP1D1 construct in which Trp residues were
mutated to Phe. As shown in Fig. 4A, the Trp residues of the CYP2J2
membrane binding region are predicted to interact with pyrene phos-
pholipids incorporated in the membrane bilayer. Using a POPC/PYR-PC
molar ratio of 64:1 the expected PYR-PC was 1 pyrene molecule per
nanodisc leaﬂet. Previously, pyrene-containing liposomes have been
successfully employed to characterize membrane insertion properties
of peripheral and integral CYPproteins [10,37,63]. Herewedemonstrate
use of PYR-ND as a new iteration of this method with a few key advan-
tages. Notably, the PYR-ND is a 10 nm discoidal lipid bilayer that is
homogeneous (Fig. 4B) and exhibits superior stability. Additionally, the
nanodisc also enables stoichiometric control of the lipid compositions.
As previously discussed, MD simulations revealed that the pyrene
moiety can sample awide range of orientations just under the phospho-
lipid heads in the membrane core. Upon insertion into the membrane
bilayer the two residues, Trp48 and Trp235, were shown to interact
with pyrene. Thus, in the presence of saturating concentrations of
PYR-ND, the experiment is a measure of membrane depth of insertion
of these ﬂuorophores.
Fig. 4. Fluorescence studies with CYP2J2 F-G loop constructs. (A) Schematic of CYP2J2 insertion into pyrene nanodiscs (PYR-ND). The F-G loop is located between the CYP2J2 F- and G-helices
(represented in blue) and contains the Trp 235 residue, which interacts with the pyrene phospholipids (shown in cyan stick model) incorporated in the membrane bilayer of nanodiscs
(phospholipids are gray and membrane scaffold protein is purple). (B) Size-exclusion HPLC chromatography of the PYR-ND. (Inset) Spectra demonstrating successful PYR-PC
phospholipids incorporation into nanodiscs. (C) The relative membrane insertion characteristics of each construct were determined by measuring CYP2J2 Trp quenching. Fo
(dashed line) is the Trp-ﬂuorescence maximum CYP2J2 in the presence of POPC nanodiscs (lacking pyrene). F (solid line) is the quenched CYP2J2 Trp ﬂuorescence due to insertion in
pyrene nanodiscs. The dotted line represents the pyrene nanodisc ﬂuorescence spectra (excitation 295 nm; emission 300–600 nm) in the absence of protein. (D) Trp ﬂuorescence signals
of CYP2J2 constructs were monitored in the presence of empty nanodiscs (F0) and presence of PYR-ND (F) to calculate F/Fo. The F/Fo was measured using PYR-ND containing POPS/POPC
molar ratios of 0:100, 30:70 and 60:40. (E) The effect of 0.5 M NaCl on F/Fo ratio was measured for each CYP2J2 F-G loop mutant using 60 mol% POPS PYR-ND.
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ratio was chosen based on ﬂuorescence titrations that revealed that the
overall Trp ﬂorescence was quenched with excess PYR-ND (data not
shown). This has been previously detailed in other cases and is thought
to reﬂect that there are two populations of Trp residues [64]. Speciﬁcal-
ly, one population that interacts with the pyrene upon insertion and
another population that is buried in the protein and is not substantially
quenched [64]. Therefore the relative extent of non-ideal Trp quenching
is represented here by the quenched ﬂuorescence (F) divided by the
initial ﬂuorescence (Fo).
The FRET transfer of energy is a dynamic quenching interaction.
Evidence of a FRET between the Trp (donor) and pyrene (quencher)
was observed upon titration of the CYP to a sample of PYR-ND. Speciﬁ-
cally, a decrease in the Trp ﬂuorescence of CYP is accompanied by an
increase in the pyrene emission (Fig. 4C). Using the PYR-ND system
we examined the relative quenching of Trp ﬂuorescence (F/Fo) as a
function of both the mol% of anionic phospholipids (POPS) and the
absence/presence of 0.5 M NaCl. The rationale of these two conditions
used is explained below.
In the absence of anionic lipids, the differences among the CYP2J2
mutants F/Fo are subtle (Fig. 4D). Speciﬁcally, Δ34, Δ34-I236D, Δ34-
F239H and Δ34-double exhibited average F/Fo ratios of 0.82 ± 0.02,
0.848 ± 0.01, 0.845 ± 0.04 and 0.89 ± 0.01, respectively. These results
suggest that the F-G loop mutants are oriented in a way that the Trp
residues are not as deeply imbedded. Overall the quenching ratios
reﬂect similar values observed with CYP3A4 binding to liposomes.
Speciﬁcally, when the Trp quenching properties of CYP3A4 were
examined with in phosphatidylcholine (PC) vesicles containing
1.5 mol% of PYR-PC the initial F/Fo values were ~ 0.85 [10]. Conversely,
in the case of CYP1A2, a negligible amount of quenching is observed
with neutral phospholipid vesicles [36].
The presence of anionic lipids is known to induce both CYP
conformational shifts as well as increased penetration into membrane
bilayers [10,36]. Thus, we further examined the membrane insertionproperties (relative F/Fo changes) of CYP2J2 when anionic lipids
(POPS) were incorporated into the bilayers of nanodiscs (Fig. 4D).
When 30 mol% of POPS was substituted at the expense of POPC, we
observed greatly enhanced differences among the F-G loop mutants
and the Δ34 construct. Speciﬁcally, Δ34, Δ34-I236D, Δ34-F239H and
Δ34-double exhibited average F/Fo ratios of 0.65 ± 0.03, 0.82 ± 0.002,
0.81 ± 0.01 and 0.84 ± 0.04, respectively. Interestingly, the differences
among the F-G loop mutants and the Δ34 construct were the most
pronounced when 60 mol% of POPS was incorporated into nanodiscs.
For these experiments, Δ34, Δ34-I236D, Δ34-F239H and Δ34-double
exhibited average F/Fo ratios of 0.52 ± 0.005, 0.74 ± 0.02, 0.7 ± 0.03
and 0.82 ± 0.002, respectively. Thus, using a high percentage of anionic
lipids we were able to affect the greatest changes between the Δ34
construct and the F-G loop mutants. While these results are only
qualitative, the different membrane binding interactions induced
by the presence of anionic lipids suggest that the hydrophobicity
and charge of the F-G loop is important for POPS mediated depth of
insertion. Speciﬁcally, these differences support the assumption
that the enzyme topology is altered when the F-G loop is mutated
with these hydrophilic residues. This conclusion is supported by
theMD data that demonstrate these residues are putative membrane
anchors and hydrophilic mutations detach this region from the
leaﬂet.
To further explore the nature of the membrane depth of insertion,
we examined the effect of a high concentration of NaCl on the F/Fo
ratio when the 60 mol% POPS PYR-ND was employed to achieve the
maximum membrane interaction of CYP2J2 (Fig. 4E). Importantly,
high salt concentrations effectively solubilizemembrane proteins, alter-
ing their nature from an irreversiblymembrane bound protein to a state
of protein that can bind and dissociate in a peripheral manner [4]. This
effect was observed when the Δ34G construct was examined, with a
decrease in the Trp quenching (F/Fo) from 0.52 to 0.71, for the no salt
buffer to 0.5 M NaCl buffer, respectively. Surprisingly, the presence of
a high concentration of NaCl had little effect on the extent of Trp
2469D.R. McDougle et al. / Biochimica et Biophysica Acta 1848 (2015) 2460–2470quenching for the F-G loopmutantswhich demonstrates themembrane
insertion depth is maintained despite the high salt concentration.
Overall, the MD simulation results and sub-cellular localization in
E. coli studies suggests that these proteins are peripherally binding in
the no salt buffer.
Here we demonstrate that the subtle topology nuances between
similar constructs and membrane depth of insertion can be measured
using Trp quenching studies. While the ﬂuorescence experiments only
provide a relative measure of membrane insertion characteristics,
this approach is an effective tool to understand how mutations, lipid
composition and NaCl can alter the depth of insertion.
4. Conclusions
In this work, we demonstrate that the CYP2J2 F-G loop region is an
important protein–membrane interface that controls membrane
insertion and substrate metabolism characteristics. The HMMMmodel
simulations revealed that CYP2J2 interacts at the F-G loop through the
Trp-235, Ille-236 and Phe-239 residues. Importantly, these binding
interactions and the protein orientation were preserved in the MD
simulations when the short-tailed lipids were extended to POPC lipids.
The effects of mutating the putative membrane anchors Ile-236 and
Phe-239 with hydrophilic residues were also examined. These muta-
tions signiﬁcantly decrease the F-G loop depth of insertion when used
in MD simulations. To experimentally corroborate these ﬁndings, four
CYP2J2 constructs (Δ34, Δ34-I236D, Δ34-F239H and Δ34-double)
were expressed in E. coli. Notably, the F-G loopmutant expression yields
derived from the membrane fraction were substantially decreased and
the protein was localized to the cytosolic fraction to a greater extent.
While all constructs demonstrated sufﬁcient P450 content and stability
we observed signiﬁcant differences in their functional metabolism.
Wild-type activity was restored through the introduction of a double
mutation F239H and I236D. Thus, we experimentally demonstrate
that the insertion of CYP2J2 into the membrane bilayers of PYR-ND is
inﬂuenced by the overall hydrophobicity of the F-G loop. The relative
membrane binding characteristics were experimentally derived by
monitoring CYP2J2 Trp quenching after insertion into the membrane
bilayers of PYR-ND. The N-terminal truncated construct Δ34-CYP2J2
exhibited membrane binding to a greater extent than the F-G loop
mutants (Δ34-I236D and Δ34-F239H) suggesting a different enzyme
topology in agreement with the MD simulations.
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